NCT00129402View on ClinicalTrials.gov

Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)

PHASE3CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Hypercholesterolemia
Interventions
DRUG

ezetimibe with simvastatin

Ezetimibe 10 mg plus simvastatin 10 mg once a day for six weeks, or Ezetimibe 10 mg plus simvastatin 20 mg once a day for six weeks, or Ezetimibe 10 mg plus simvastatin 40 mg once a day for six weeks

DRUG

simvastatin

Ezetimibe matching placebo plus simvastatin 10 mg once a day for six weeks, or Ezetimibe matching placebo plus simvastatin 20 mg once a day for six weeks, or Ezetimibe matching placebo plus simvastatin 40 mg once a day for six weeks

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00129402 - Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579) | Biotech Hunter | Biotech Hunter